UK markets open in 5 hours 21 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
158.02+2.72 (+1.75%)
At close: 04:03PM EDT
158.24 +0.22 (+0.14%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close155.30
Bid157.50 x 800
Ask158.24 x 800
Day's range154.59 - 158.48
52-week range134.09 - 175.91
Avg. volume6,384,056
Market cap278.769B
Beta (5Y monthly)0.59
PE ratio (TTM)23.41
EPS (TTM)6.75
Earnings date27 Apr 2023 - 01 May 2023
Forward dividend & yield5.92 (3.81%)
Ex-dividend date13 Apr 2023
1y target est163.87
  • Motley Fool

    Better Buy: AbbVie vs. Johnson & Johnson

    AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.

  • Zacks

    Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL

    Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951

  • Motley Fool

    2 High-Yield Dividend Stocks You Won't Regret Buying Right Now

    High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.